B9X-74060-90089
2 vaccinations
1 coded response
3 check-ins
0 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 05-11
- ZIP prefix
- 993 / WA
- Registered
- 2022-06-01
- Relationship
- Child or adolescent in my care
- Guardian
- 4RJ-22850-06667
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2022-01-31
Dose 1 — Pfizer-BioNTech
-
2022-03-27
Dose 2 — Pfizer-BioNTech
-
2022-06-01
Registered in v-safe
- 2022-06-26
- 2022-09-25
-
2023-03-27
Survey response — 12 months, dose 2, dependentMedDRA: Cardiovascular symptom, Heart rate increased, Heart rate irregular, Self-medication — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-01-31 | Pfizer-BioNTech | No |
| 2 | 2022-03-27 | Pfizer-BioNTech | No |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cardiovascular symptom | · | · | ✓ |
| SD | Heart rate increased | · | · | ✓ |
| SD | Heart rate irregular | · | · | ✓ |
| SD | Self-medication | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release